ZoneOne Pharma Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.38M

  • Investors
  • 2

ZoneOne Pharma General Information

Description

Developer of medical company intended to develop next-generation liposomal technology. The company develops liposomal chelator therapeutics with contract formulation of liposome drugs and matches drugs with chemistry and biology in order to develop therapies that meet clinical needs, enabling physicians to accelerate the preclinical development of therapeutic cures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Therapeutic Devices
Corporate Office
  • 1700 4th Street
  • Suite 219
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ZoneOne Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2016 $2.38M Completed Generating Revenue
4. Grant 01-Jan-2015 00.000 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 01-Jan-2013 $161K Completed Generating Revenue
1. Grant 01-Jan-2012 $216K Completed Generating Revenue
To view ZoneOne Pharma’s complete valuation and funding history, request access »

ZoneOne Pharma Patents

ZoneOne Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170231910-A1 Pharmaceutical formulations of chelating agents as a metal removal treatment system Inactive 13-Aug-2014 0000000000 0
US-20170239182-A1 Pharmaceutical formulations of and methods to prepare chelating agents for efficient metal removal treatment systems Inactive 13-Aug-2014 000000000 0
AU-2015301234-A1 Remote loading of sparingly water-soluble drugs into lipid vesicles Inactive 04-Aug-2014 00000000000
EP-3177269-A1 Remote loading of sparingly water-soluble drugs into lipid vesicles Inactive 04-Aug-2014 00000000000
EP-3177269-A4 Remote loading of sparingly water-soluble drugs into lipid vesicles Inactive 04-Aug-2014 A61K31/7048 0
To view ZoneOne Pharma’s complete patent history, request access »

ZoneOne Pharma Executive Team (4)

Name Title Board Seat Contact Info
Charles Noble Ph.D Co-Founder, Founding Partner, Founding Scientist & President
Peter Working Ph.D Co-Founder & Director of Regulatory Affairs
Francis Szoka Ph.D Co-Founder & Chairman
Mark Hayes Ph.D Co-Founder & Board Member
To view ZoneOne Pharma’s complete executive team members history, request access »

ZoneOne Pharma Board Members (3)

Name Representing Role Since
Francis Szoka Ph.D ZoneOne Pharma Co-Founder & Chairman 000 0000
Mark Hayes Ph.D ZoneOne Pharma Co-Founder & Board Member 000 0000
Michael Motion Ph.D Self Board Member 000 0000
To view ZoneOne Pharma’s complete board members history, request access »

ZoneOne Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
QB3 Accelerator/Incubator 000 0000 000000 0
To view ZoneOne Pharma’s complete investors history, request access »

ZoneOne Pharma FAQs

  • When was ZoneOne Pharma founded?

    ZoneOne Pharma was founded in 2011.

  • Who is the founder of ZoneOne Pharma?

    Charles Noble Ph.D, Peter Working Ph.D, Francis Szoka Ph.D, and Mark Hayes Ph.D are the founders of ZoneOne Pharma.

  • Where is ZoneOne Pharma headquartered?

    ZoneOne Pharma is headquartered in San Francisco, CA.

  • What industry is ZoneOne Pharma in?

    ZoneOne Pharma’s primary industry is Pharmaceuticals.

  • Is ZoneOne Pharma a private or public company?

    ZoneOne Pharma is a Private company.

  • What is ZoneOne Pharma’s current revenue?

    The current revenue for ZoneOne Pharma is 000000.

  • Who are ZoneOne Pharma’s investors?

    U.S. Department of Health and Human Services and QB3 have invested in ZoneOne Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »